0001488745-12-000002.txt : 20120111 0001488745-12-000002.hdr.sgml : 20120111 20120111144726 ACCESSION NUMBER: 0001488745-12-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120111 DATE AS OF CHANGE: 20120111 EFFECTIVENESS DATE: 20120111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Auspex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001454189 IRS NUMBER: 954862842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-171586 FILM NUMBER: 12521937 BUSINESS ADDRESS: STREET 1: 1261 LIBERTY WAY STREET 2: SUITE C CITY: CARLSBAD STATE: CA ZIP: 92081-8356 BUSINESS PHONE: (760) 599-1800 MAIL ADDRESS: STREET 1: 1261 LIBERTY WAY STREET 2: SUITE C CITY: CARLSBAD STATE: CA ZIP: 92081-8356 D 1 primary_doc.xml X0704 D LIVE 0001454189 Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Court SUITE 225 La Jolla CA CALIFORNIA 92037 (858) 558-2400 DELAWARE None None Corporation true 2007 Pratik Shah c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Court, Suite 225 La Jolla CA CALIFORNIA 92037 Director David Collier c/o CMEA Ventures One Embarcadero Center, Suite 3250 San Francisco CA CALIFORNIA 94111 Director Sepehr Sarshar c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Court, Suite 225 La Jolla CA CALIFORNIA 92037 Director Samuel Saks c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Court, Suite 225 La Jolla CA CALIFORNIA 92037 Director David A. Stamler c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Court, Suite 225 La Jolla CA CALIFORNIA 92037 Executive Officer Andreas Sommer c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Court, Suite 225 La Jolla CA CALIFORNIA 92037 Executive Officer Lawrence C. Fritz c/o Auspex Pharmaceuticals, Inc. 3366 N. Torrey Pines Court, Suite 225 La Jolla CA CALIFORNIA 92037 Executive Officer Director Pharmaceuticals Decline to Disclose 06 false 2011-12-15 false true true true Promissory Notes convertible into Preferred Stock and Warrants to purchase shares of Preferred Stock were issued in connection with the Offering. false 0 6000000 3000000 3000000 Warrants for the purchase of Pref Stock were issued at the Offering. No additional consideration was received for the Warrants. The # of warrant shares issuable upon exercise of the Warrants is contingent upon a formula set forth in each of the Warrants. false 7 0 0 0 false Auspex Pharmaceuticals, Inc. Lawrence C. Fritz Lawrence C. Frtiz President and CEO 2011-12-28